Regenicin (RGIN) Short Interest Ratio & Short Volume

Short interest is the volume of Regenicin shares that have been sold short but have not yet been covered or closed out. As of April 30th, traders have sold 2,900 shares of RGIN short. Learn More on Regenicin's current short interest.

Regenicin saw a decrease in short interest during the month of April. As of April 30th, there was short interest totaling 2,900 shares, a decrease of 25.6% from the previous total of 3,900 shares. Changes in short volume can be used to identify positive and negative investor sentiment. Investors that short sell a stock are betting that its price will decline in the future. An increase in short sale volume suggests bearish (negative) sentiment among investors. A decrease on short sale volume suggests bullish (positive) sentiment.

Here is how the short interest of companies in the sector of "medical" compare to Regenicin: Motus GI Holdings, Inc. (0.46%), QHSLab, Inc. (0.10%), Sintx Technologies, Inc. (5.38%), Bluejay Diagnostics, Inc. (0.65%), INVO Bioscience, Inc. (0.47%), Nemaura Medical Inc. (0.34%), ReShape Lifesciences Inc. (3.50%), Quoin Pharmaceuticals, Ltd. (0.31%), Dynatronics Co. (0.57%), Tenon Medical, Inc. (3.32%),

As of the most recent reporting period, the following stocks had the largest short interest positions: Aon plc ($6.19 billion), Charter Communications, Inc. ($5.76 billion), Analog Devices, Inc. ($5.70 billion), S&P Global Inc. ($5.03 billion), Airbnb, Inc. ($4.01 billion), Snap Inc. ($3.54 billion), Nuance Communications, Inc. ($2.72 billion), Expedia Group, Inc. ($2.31 billion), The Kroger Co. ($2.25 billion), and GameStop Corp. ($2.05 billion). View all of the most shorted stocks.

Short selling RGIN is an investing strategy that aims to generate trading profit from Regenicin as its price is falling. To short a stock, an investor borrows shares, sells them and buys the shares back on the public market later to return it to the lender. Short sellers are betting that a stock will decline in price. If the stock does drop after selling, the short seller buys it back at a lower price and returns it to the lender. The difference between the sell price and the buy price is the trader's profit.

A short squeeze for Regenicin occurs when it has a large amount of short interest and its stock appreciates in price. This forces short sellers to cover their short interest positions by buying actual shares of RGIN, which in turn drives the price of the stock up even further.

Short interest is typically published by a stock exchange once per month. However, NASDAQ publishes a report for U.S. stocks, including RGIN, twice per month. The most recent reporting period available is April, 30 2021.